Artificial intelligence (AI) is transforming how we solve problems, make decisions, and address some of the world’s most complex challenges. Advancing AI responsibly requires more than technology alone.
An interview with George, GSK Medical Science Liaison Director. George has his Pharm.D., is based in Dallas, TX, has worked for GSK for fourteen years, and manages of a team of eight other MSLs.
An interview with Linda, GSK Community Partnership Representative, 26-year employee of GSK, the second in a three-generation family of GSK’ers, and a Philadelphia native.
GSK released our Annual Report and Responsible Business Supplement, which outlines our progress against 23 bold commitments to be a better business. I invite you to go on this journey with me. Below, you can click through to learn what it’s like and what it takes for four GSK US “intrapreneurs” to build healthier communities, transform our commercial model, reduce our environmental footprint, and create a more diverse and inclusive workforce.
In 2015, Comcast and NBC Sports Champions, the pro-social initiative of NBC Sports Group, teamed up to provide more than 150 young people from 15 Boys & Girls Clubs across the country with behind-the-scenes technology experiences at America’s biggest sporting events.
Founded in 1999, the Comcast Foundation focuses on connecting and strengthening communities by supporting programs that expand digital literacy, promote community service, and build tomorrow’s leaders.
In 2015, the Foundation donated more than $18 million to more than 1,100 nonprofit organizations nationwide that focus their efforts on the communities Comcast serves. The Gads Hill Center, founded more than a century ago and based in a struggling Chicago neighborhood, is one of those nonprofits.
GM CEO Mary Barra has stated the auto industry will change more in the next five years than it has in the last 50. What’s in store, and how will the fusion of transportation and connectivity enable new ways to share mobility?
Moncef Slaoui, Chairmman, GSK Vaccines, has been named to FORTUNE’s third annual list of “World’s Greatest Leaders.” Ranked at No. 29, Moncef is recognized for his groundbreaking work on Mosquirix™ Cervarix® and Synflorix® and the personal motivation behind his focus on under-researched diseases.
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
